Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

Completed · Phase 3

Conditions studied: Alzheimer Disease

In brief

The purpose of this trial is to test the ability of the non-steroidal anti-inflammatory medications naproxen and celecoxib to delay or prevent the onset of AD and age-related cognitive decline.

Key facts

Study ID
NCT00007189
Run by
Seattle Institute for Biomedical and Clinical Research
People needed
2625
Starts
2001-01-01
Last updated by the study team
2016-10-19

Who can join

Age: 70 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.